AXOGEN INC
AXGNNASDAQ🏆 #1515 by market capEarnings Nov 4US Equity
$48.48▲ $0.26 (+0.54%)
Market closed · at close1h—
24h▲ 0.5%
7d▲ 7.2%
14d▲ 17.2%
30d▲ 22.7%
1y▲ 242.1%
🏦Market Cap
$2.61B
Small Cap
📈Revenue Growth (YoY)
+23.6%
Healthy
📊Gross Margin
74.6%
High
💵FCF Margin
3.1%
Moderate
⚖️P/S Ratio
9.9x
Elevated
Otter Score
55
Weak
📊
Analyst Ratings
Price
$48.48
Total
19
Raised
1
Lowered
3
Avg PT
$50.17
H / L
$55 / $40
| Institution | Action | Rating | Date |
|---|---|---|---|
Canaccord Genuity | Reiterated | Buy | 2026-07-30 |
Citizens | Reiterated | Market Outperform | 2026-07-30 |
HC Wainwright & Co. | Reiterated | Buy | 2026-07-30 |
Wells Fargo | Reiterated | Overweight | 2026-04-29 |
Lake Street | Reiterated | Buy | 2026-04-23 |
Jefferies | Reiterated | Buy | 2025-12-04 |
Raymond James | Reiterated | Outperform | 2025-10-30 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-03-05 |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-03-05 |
JMP Securities | Reiterated | Market Outperform | 2024-08-09 |
SVB Leerink | Reiterated | Outperform | 2022-05-05 |
Guggenheim | Reiterated | Buy | 2020-10-23 |
BTIG | Downgraded | Buy → Neutral | 2020-04-02 |
William Blair | Downgraded | Outperform → Market Perform | 2019-08-07 |
BTIG Research | Upgraded | Neutral → Buy | 2019-03-25 |
Leerink Swann | Reiterated | Outperform | 2017-11-21 |
Roth Capital | Reiterated | Buy | 2017-03-06 |
Ladenburg Thalmann | Downgraded | Buy → Neutral | 2015-04-01 |
Wedbush | Reiterated | Outperform | 2015-03-12 |
One row per institution, most recent rating